CAR T-cell therapy is showing promise
This specific therapy is showing promising results in early clinical trials against lymphomas that are difficult to treat. Healthcare professionals are improving how they make the T-cells and they are learning the best ways to use them.
At present, there is only one FDA approved CAR T-cell therapy for certain types of advanced or recurrent large B-cell lymphoma. CAR T-cell therapy for other types of non-Hodgkin’s lymphoma is solely available in clinical trials at the moment.